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Abstract 
The yeast Saccharomyces cerevisiae is one of the oldest and most frequently used microorganisms in biotechnology 
with successful applications in the production of both bulk and fine chemicals. Yet, yeast researchers are faced with 
the challenge to further its transition from the old workhorse to a modern cell factory, fulfilling the requirements for 
next generation bioprocesses. Many of the principles and tools that are applied for this development originate from 
the field of synthetic biology and the engineered strains will indeed be synthetic organisms. We provide an overview 
of the most important aspects of this transition and highlight achievements in recent years as well as trends in which 
yeast currently lags behind. These aspects include: the enhancement of the substrate spectrum of yeast, with the 
focus on the efficient utilization of renewable feedstocks, the enhancement of the product spectrum through genera-
tion of independent circuits for the maintenance of redox balances and biosynthesis of common carbon building 
blocks, the requirement for accurate pathway control with improved genome editing and through orthogonal pro-
moters, and improvement of the tolerance of yeast for specific stress conditions. The causative genetic elements for 
the required traits of the future yeast cell factories will be assembled into genetic modules for fast transfer between 
strains. These developments will benefit from progress in bio-computational methods, which allow for the integra-
tion of different kinds of data sets and algorithms, and from rapid advancement in genome editing, which will enable 
multiplexed targeted integration of whole heterologous pathways. The overall goal will be to provide a collection of 
modules and circuits that work independently and can be combined at will, depending on the individual conditions, 
and will result in an optimal synthetic host for a given production process.
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Background
The development of economically feasible and sustaina-
ble biotechnological processes as alternatives to oil based 
chemistry is one of the major goals of biobased economy. 
The success of this strategy will require efficient, robust 
and versatile cell factories but the improvement of cur-
rently used strains towards such platforms is hindered 
by the limitations of conventional methods for strain 
improvement. Synthetic biology is expected to provide 
means for engineering cell factories in a more efficient 
and controllable way.
Synthetic biology is regarded as the engineering dis-
cipline by which novel organisms can be constructed 
by assembling parts, devices and modules into systems. 
Proponents such as the iGEM (International Genetically 
Engineered Machine) foundation aim at a high level of 
standardization and foster the definition of a framework 
of rules for the conceptualization, design and manufac-
ture of biological systems with predictable properties. A 
more practical, problem driven approach, however, sees 
synthetic biology as the field that makes use of advanced 
tools of genetic engineering, genomics and systems 
biology in order to programme and control a biological 
device and create new behaviour previously not found 
in that system. In contrast to the former approach, this 
description does not draw a clear line to other sciences; 
the designation of a strain as simply genetically engi-
neered or synthetic seems rather arbitrary. Because of the 
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complexity of biological systems, each problem is seen 
as unique and the occurrence of unpredictable effects of 
genetic modifications is expected, making attempts for 
standardization a futile effort. Irrespective of the ongoing 
debate about its definition [1, 2], there is general agree-
ment that the success of synthetic biology in biotech-
nology will rely on the development of new methods to 
analyse and control cell systems and to allow for the tar-
geted modification of genomes on a large scale. Hence, 
with the advance of recent genome editing techniques, of 
next generation sequencing and gene synthesis, and the 
merging of large datasets with modelling and novel bio-
informatics tools, we expect that synthetic biology will 
significantly advance the design of industrially relevant 
strains for producing novel chemicals.
The yeast Saccharomyces cerevisiae is the most inten-
sively studied unicellular eukaryote and one of the main 
industrial microorganisms used in the production of bio-
chemicals. Apart from traditional applications in alcohol 
fermentations, baking processes and bio-ethanol pro-
duction, S. cerevisiae is being used for the production of 
many industrially relevant biochemicals and for heter-
ologous expression of proteins [3]. The potential of yeast 
as a powerful host for synthetic biology has already been 
successfully demonstrated by both basic research, namely 
the de novo synthesis of a complete chromosome [4], and 
the application-oriented engineering of complex path-
ways, like the synthesis of amorphadiene and vanillin [5, 
6].
There are two basic strategies for developing a produc-
tion host for a biotechnological process. In the first, a 
suitable host can be selected from a large number of spe-
cies based on its performance regarding parameters such 
as product yield, productivity, and tolerance to the prod-
uct or other environmental stressors (e.g. pH, tempera-
ture, salt). In many cases, targeted optimization of such a 
host is not possible because the tools for genetic analysis 
and engineering in that species are not available, leav-
ing only evolutionary optimization or random mutagen-
esis to produce optimized strains. The second possible 
strategy is to start with a well-known species such as S. 
cerevisiae and optimize it for the desired product and 
required bioprocess conditions. Many examples for this 
strategy exist, but species-specific traits often hinder the 
development of hosts with high productivity and yields 
close to theoretical limits. Nevertheless, S. cerevisiae is 
the host of choice in many cases, due to the vast array of 
tools for genetic engineering and to the immense range 
of knowledge about all aspects of yeast biology. In this 
review, we will highlight recent achievements in engi-
neering S. cerevisiae for biotechnological processes, with 
focus on advanced synthetic biology tools for genome 
editing, pathway control and for the analysis and transfer 
of industrially relevant traits. Moreover, we will discuss 
further developments that will be required to establish S. 
cerevisiae as one of the chassis in synthetic biology and as 
a platform for future cell factories. Finally, we will present 
an approach whereby both aforementioned strategies 
for strain development can be combined in a synergistic 
manner, to obtain a platform strain that can be individu-
ally adapted according to the requirements of a specific 
process.
Development of genome editing tools
Traditional DNA editing techniques, such as transfor-
mation and deletion of genes by homologous recom-
bination, have been readily feasible for many years in S. 
cerevisiae. The use of Cre recombinase or other recom-
bination based approaches, like the 50:50 method [7], 
allow for marker recycling and performing delitti perfetti, 
leaving no foreign DNA in the yeast genome. Although 
such techniques are currently an important tool for syn-
thetic biology, they are relatively time consuming and 
therefore not suitable for the introduction of whole het-
erologous metabolic pathways or deletions of several 
genes in a reasonably short time. In the last few years, 
new approaches like Zinc finger nucleases [8], Yeast 
Oligo-Mediated Genome Engineering (YOGE) [9], tran-
scription activator like (TAL) effector nucleases [10] and 
the CRISPR-Cas system (clustered regularly interspaced 
short palindromic repeats) [11, 12] have been developed 
for deleting or inserting genes and for controlling gene 
expression. The main advantages of these tools over tra-
ditional techniques lie in their efficiency, accuracy and 
speed. They all rely on site-specific endonucleases form-
ing a double strand break that is repaired either with 
non-homologous end joining or homology-directed 
repair. The versatility of the methods stems from the abil-
ity to customize the DNA binding domains, allowing for 
site-specific genome editing. From the techniques men-
tioned, the use of CRISPR, together with the site specific 
Cas9 endonuclease, appears as the most promising tool 
for editing a genome at any number of different loci in 
a short time. Remarkably, DiCarlo et al. reported a close 
to 100% recombination efficiency of a linear dsDNA after 
transformation, together with a plasmid bearing the 
guiding RNA [11]. Similar approaches were already used 
for multiplex deletions of up to five genes [13, 14]. Hence, 
the CRISPR/Cas9 tool makes the use of marker-flanked 
integration cassettes obsolete and paves the way for rapid 
and efficient genome editing.
Other approaches make use of the high recombination 
efficiency of S. cerevisiae by simultaneous transformation 
of a recipient strain with several different integration cas-
settes. One successful strategy used up to four cassettes, 
with each one containing two genes under the control 
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of the bidirectional GAL1/10 promoter and a phleomy-
cin resistance marker, and with targeted chromosomal δ 
sites of transposons. An alternative approach, the DNA 
assembler technique, is based on the in vivo recombina-
tion of overlapping DNA sequences. All genes of a path-
way together with a marker were amplified by PCR with 
extension primers that resulted in overlapping sequences 
at the 3′-end of one gene and the 5′-end of the next one. 
The 5′-end of the first and the 3′-end of the last cassette 
bore sequences homologous to sequences in the chro-
mosomal δ sites. For both strategies, pathways with up 
to eight genes were successfully assembled in one round 
of transformation [15, 16]. These approaches reduce the 
risk of undesirable background mutations in the recipi-
ent strain, since only one transformation is required. The 
use of δ sites, which are highly abundant in the genome, 
probably increases the efficiency of these methods. On 
the other hand, the exact positions of the integrated cas-
settes are not known and their numbers could vary, either 
as a result of different integration efficiencies or, later 
on, due to duplication of transposons. However, these 
drawbacks may be overcome when such methods are 
combined with one of the abovementioned techniques 
of targeted integration through endonucleases at unique 
loci. Indeed, a recent study demonstrated the potential of 
such a combination with the successful co-transforma-
tion of 15 linear DNA fragments, their in vivo assembly 
into 3 genes and targeted integration by Cas9 and gRNA 
[17]. The rate of positive transformants was too low to 
be used for a marker-free strategy. Nevertheless, if such 
approaches prove to be generally applicable, extensive 
genetic engineering will no longer be limited by the time 
consuming introduction or deletion of one gene after the 
other. Furthermore, it will be possible to obtain strains 
with different combinations of genetic modifications 
by single transformations, e.g. by co-transformation of 
alternative heterologous genes coding for the same enzy-
matic function. The resulting strains can then be tested 
for performance regarding a desired trait. The drawback 
of the CRISPR/Cas9 technique, especially in the context 
of multiplex engineering, is the requirement for a specific 
gRNA plasmid for each target locus (or for one plasmid 
with several gRNA sequences). However, we expect that 
gRNA libraries will soon become available. Such collec-
tions could provide plasmids with guiding sequences that 
target loci with high transcriptional activity on different 
chromosomes and could be used for the simultaneous 
insertion of several genes of a heterologous pathway.
The currently most ambitious project in yeast synthetic 
biology is the complete de novo synthesis of all 16 chro-
mosomes, Sc2.0. In this effort, all nonessential genes 
will be flanked by loxP sites, allowing for random dele-
tion of genes upon expression of Cre recombinase and on 
screening for viable strains with improved characteristics 
for a selectable trait. Furthermore, one of the three stop 
codons will be eliminated from the genome in this pro-
ject. In the future, an orthogonal codon could be used 
for the targeted incorporation of an alternative amino 
acid, thereby altering protein properties. Such a recoded 
genome will also enable the development of efficient bio-
containment strategies as the free codon can be used to 
engineer orthogonal auxotrophies in cell factories to 
minimize risk in the case of accidental release and allow 
for processes to be carried out in open bioreactors [18, 
19]. Although this project is at its very beginning, with 
one synthetic chromosome completed [4], the consor-
tium plans to finish all additional chromosomes until 
2019 [20]. It is thus not yet clear whether replacement 
of all chromosomes with their synthetic analogues will 
be possible, but Sc2.0 will certainly provide new knowl-
edge about the genetics of yeast and genome editing. The 
rearrangement of tRNAs and elimination of transpos-
able elements might be seen as one of the most interest-
ing aspects of this project. The proponents argue that 
this strategy will lead to genome stabilization [4]. How-
ever, increased instability of the “party chromosome”, an 
additional chromosome that will bear all tRNA coding 
sequences, has to be expected. If these alterations will 
indeed result in overall increased genome stability, such 
a strategy could become useful to improve the robustness 
of cell factories.
Development of orthogonal systems
One of the central aims of synthetic biology is to apply 
classical engineering principles to the development of 
strains. This includes the concept of orthogonality that 
requires a biological system to be divisible into modules 
that are independent from each other and can therefore 
be engineered individually, without consideration of 
other modules and with predictable outcome (Figure 1). 
In contrast, system-wide approaches like systems biology 
and the various -omics techniques teach us that virtu-
ally each part of a biological system could be respond-
ing to changes in another part, with spatial, temporal or 
functional causalities that are often difficult or impossi-
ble to predict with our current knowledge. Hence, abso-
lute orthogonality may, in the near future at least, not be 
achievable for biological devices.
Approaches in this field that go beyond theoretical 
considerations include the synthetic yeast strain with 
an orthogonal codon on the DNA level (see above), 
the engineering of aminoacyl-tRNA synthetases [21], 
riboregulators [22], and orthogonal ribosomes [23] on 
the translational level, and enzymes with specificity for 
orthogonal co-factors like xanthosine 5′-triphosphate 
[24] on the level of enzyme activity. Such studies will 
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undoubtedly contribute considerably to the implementa-
tion of orthogonality in synthetic biological systems. For 
biotechnology applications, however, it seems unlikely 
that any of these approaches will be of relevance, even in 
the medium term, because they are too far from trans-
lation into production hosts and because there is no 
obvious, industrially relevant, advantage of such sys-
tems over existing, non-orthogonal, hosts. In contrast, 
orthogonality on the level of pathway control would be 
very important for the optimization of strains. Transcrip-
tional control is the most common means of regulating 
the flux through a pathway. In S. cerevisiae, the majority 
of promoters that are used for control of expression are 
endogenous promoters that respond to the concentration 
and type of the carbon source [25]. Besides, inducible 
systems have been developed that respond to amino acid 
availability (MET15), to metal ions (CUP1) or to anti-
biotics, like the well-established tetR/tetO system [26], 
but, similar to the carbon source dependent promoters, 
these modules cannot be used for orthogonal expression. 
Regarding the possible complexity of the network that 
has to be controlled in a synthetic organism, it would be 
most advantageous to have a set of transcription factors 
(TFs) that are identical in their DNA binding proper-
ties but activatable by different chemical inducers, pos-
sibly at extremely low concentrations and in a titratable 
manner. Because of the requirement for orthogonality, 
these inducers are expected to cause no other response 
in yeast. Promising examples for transcriptional orthog-
onality are the estradiol-inducible chimeric TF [27], 
the retinoid X receptor [28], and the bacterial quorum 
sensing TF luxR [29], which has not yet been tested in 
S. cerevisiae. The advantage of these systems is that the 
ligand binding domain can be mutated to bind, with high 
specificity, a number of different, although structurally 
related, ligands. Starting from one TF, such mutations 
Figure 1 The assembly of a multi-trait yeast cell factory. The future yeast cell factory strains will require combinations of several traits, each of which 
will be encoded by a specific genetic module (depicted by strings of arrows) engineered using the state-of-the-art synthetic biology approaches, 
such as marker-free multiplex genome editing and orthogonal promoter libraries. In the future, individual “ready-to-use” modules should become 
available for fast transfer of the desired traits to the recipient strain in any combination. The order in which the respective modules are introduced 
will depend upon the specific conditions/requirements. Left Depending on the biotechnological process, different robustness traits will have to be 
introduced into the starting strain (e.g. tolerance to extreme pH, osmotic stress, organic acids or other toxic substances). Following the isolation of 
strains with superior performance with regard to specific traits (depicted by different colours), causal genes can be identified by polygenic trait analy-
sis and/or by bioinformatics methods, as described in the text. Centre Optimization of the strains for efficient utilization of renewable feedstocks is 
another important aspect in engineering multi-trait yeast cell factories. Utilization of pentoses, especially xylose, and in the future also of lignin, will 
enable more cost-effective production of biochemicals. The next generation of yeast cell factories will be capable of consolidated bioprocessing 
(CBP), as described in the text. Right The biosynthesis pathway for the desired product could consist of a number of endogenous and/or heterolo-
gous genes. These genes will be combined with standard modules that will provide common building blocks or contribute to cofactor balance 
(The image in “B” is a detail from “Champs DSC01354" by Daplaza, licensed under CC BY-SA 2.5).
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would result in a series of variants with identical binding 
but different activation domains. Most such approaches 
in yeast, however, use the binding domain of the GAL4 
TF. For this reason, although these engineered systems 
work independently of galactose induction, they inter-
fere with genes of this regulon and activate their tran-
scription upon induction. To obtain modules that can be 
controlled orthogonally, foreign binding mechanisms will 
have to be used. As noted in the previous section, genome 
editing tools can be used, not only for targeted modifi-
cations of DNA, but also for the control of gene expres-
sion. For example, the TAL effector can be designed to 
bind to any specific DNA sequence with high specificity; 
it has already been demonstrated to work as a repres-
sor of a constitutive promoter in yeast [30]. A CRISPR/
Cas9 system with a mutated and inactive endonuclease 
can be used in a similar manner [31]. If the DNA bind-
ing domains of these bacterial systems can be combined 
with chemically gradable activation domains, they will 
probably provide a highly efficient tool for the fine-tuned 
orthogonal expression of synthetic pathways.
Predicting improved robustness and stress 
tolerance
Biotechnological processes often require strains that are 
tolerant to one or several stress conditions from a broad 
spectrum, like extreme pH, high temperature, osmotic 
pressure, shearing forces, organic acids and toxic sub-
stances. Most of these properties are complex traits, 
encoded by several genes (Figure  1, left). Basic genetic 
analysis methods therefore fail to characterize the under-
lying genetic network, and efforts to optimize one of 
these traits traditionally rely on adaptive evolution or 
breeding strategies. The possibilities of whole genome 
sequencing at low cost and in a comparably short time 
have now opened the way for the use of advanced genome 
analysis tools like quantitative trait loci (QTL) analysis 
to identify, at least under some conditions, all causative 
genes for a certain trait [32] or even several different 
genetic combinations giving rise to the same phenotype 
[33]. Extreme QTL (X-QTL) analysis and intercross QTL 
(iQTL), which have recently been improved greatly, pro-
vide sensitivity and detection of even modest changes in 
a trait to a single gene or even nucleotide level, simulta-
neously covering all causal loci contributing to heritabil-
ity of the trait [32, 34].
These complex genetics techniques use the advantages 
of next generation sequencing capabilities to greatly 
increase the number of segregants that can be tested, 
but also produce more data that cannot be interpreted 
with traditional computational tools. To infer causative 
relationships between loci/genes and complex traits, 
novel data integration models are applied. While it is a 
common practice to apply conventional statistical test-
ing on SNP polymorphisms for QTL discovery, it has 
been observed that a larger number of additional known 
factors can influence the resulting phenotype [35–37]. 
Existing methods can be tailored to integrate additional 
known factors, such as: the expression levels of tran-
scripts, proteins or metabolites, transcription factor 
binding data, gene annotations and metabolic pathways, 
environmental conditions, experimental procedures as 
well as related phenotypes themselves. Complementary 
to observable factors, probabilistic Bayesian frameworks 
can be applied in order to account for unobservable, hid-
den factors [38], e.g. cell culture conditions, uncovering 
additional QTL-related features and further improving 
detection. A collection of data sources thus constitutes 
a comprehensive genome-wide polygenic trait detection 
model, useful in both laboratory and industrial experi-
mental design. Current machine learning research is 
focusing on efficient data integration algorithms, such 
as matrix factorization [39], Bayesian networks [40] and 
multivariate regression [41], exploiting multiple data 
sources and accounting for both known and hidden fac-
tors. The additional information gained from multiple 
views on the data will improve various learning tasks, 
including gene prioritization, prediction or classifica-
tion, potentially reducing the number of experimen-
tal assays required to investigate a given hypothesis. 
Another related and important property of these meth-
ods is the ability to include a variety of data sources 
without explicit tailoring of methods for each data type. 
This could prove particularly important, since synthetic 
biology is constantly providing new means for manipu-
lating and designing industrially relevant strains, such 
as pathway engineering, RNA parts and devices, protein 
engineering or design of novel gene regulatory networks 
[42], with the potential of generating large quantities of 
experimental data of a strain response to single or multi-
ple manipulations.
The aforementioned methods enable integration of 
data on mutations, environmental conditions [43, 44] 
and strain efficiency [45, 46]. As such, they will aid in the 
discovery of promising combinations of genetic manipu-
lations, strains and environmental conditions to achieve 
multiple engineering objectives such as yield or breeding 
efficiency [44], as well as meeting productivity, efficiency 
or robustness constraints. Combining the knowledge of 
causative gene networks and metabolic models, it is pos-
sible to predict side effects and other trade-offs asso-
ciated with manipulations. The main consequence of 
applying integrative mathematical modelling is, and will 
remain, the significant speed-up gained by informed 
manipulations comparing over the traditional trial-and-
error approach.
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Improvement of the substrate spectrum
The metabolism of S. cerevisiae is specialized for the uti-
lization of glucose, fructose and its disaccharide sucrose. 
In the emerging era of bioeconomy, however, microbial 
cell factories will have to efficiently utilize more sustain-
able, cheaper and generally available carbon sources, 
especially lignocellulose [47, 48] (Figure 1, centre). S. cer-
evisiae cannot directly utilize cellulose and therefore pre-
treatment is required to release glucose (see below).The 
second most abundant monosaccharide in plant biomass 
is xylose, but the rate of xylose metabolism in currently 
used laboratory and industrial yeast strains is too slow to 
be of use in a biotechnological process, especially because 
of too low xylitol dehydrogenase (XDH) activity [49, 50]. 
Adaptive evolution experiments resulted in strains with 
increased XDH activity and significantly shorter doubling 
times on xylose as the sole carbon source [51]. Moreo-
ver, several wine strains have been found that harbour 
in their genomes a previously unknown XDH-encoding 
gene named XDH1 [52], indicating that it may be pos-
sible in the future to engineer an efficient endogenous 
xylose utilization pathway. Still, currently the most effi-
cient utilization of xylose as the carbon source requires 
introduction of heterologous pathways, most often bac-
terial xylose isomerase. To construct the currently most 
efficient pentose fermenting strain published, a cassette 
of 13 genes, coding for enzymes of the xylose and arab-
inose utilization pathways and of the pentose phosphate 
pathway, was inserted into the genome of an industrial 
strain. Together with mutagenesis, genome shuffling and 
evolutionary engineering, the authors obtained a strain 
that produced 32% more ethanol from lignocellulosic 
hydrolysates than the parent strain. Although at lower 
consumption rates than for glucose, this synthetic strain 
fermented xylose to ethanol with yields close to the theo-
retical maximum [53].
The knowledge from decades of research on the uti-
lization of lignocellulose-derived sugars is now being 
transferred to yeast-based processes and several second 
generation ethanol plants have recently started produc-
tion or will do so in the near future [54]. The cell facto-
ries in these plants, however, mainly utilize glucose and 
xylose, whereas most other components of lignocellulose 
are regarded as waste. This is especially true for lignin, 
which composes up to 40% of lignocellulosic biomass. 
Although many of the enzymes required for lignin degra-
dation are known, only little work is being done to trans-
fer this knowledge to yeast and to develop lignin utilizing 
strains. Given the heterogeneity and complexity of lignin, 
the efficiency of its degradation pathways in S. cerevisiae 
is currently not predictable. Nevertheless, lignin utiliza-
tion should be seen as a long-term goal for the sustain-
able utilization of renewable feedstocks.
Since direct utilization of lignocellulosic material as a 
feedstock for yeast is not yet possible, thermal, chemical 
and/or enzymatic pretreatments are required to separate 
the polymers that constitute lignocellulose and release 
the sugar monomers. Subsequent detoxification is often 
necessary to remove pretreatment derived inhibitory sub-
stances—especially acetic acid, formic acid, furan deriva-
tives and phenolic compounds. Mechanisms conferring 
tolerance to such inhibitory substances can be predicted 
and engineered in yeast (see below), but development 
in this field has until now brought only limited success, 
although with promising predictions for the future [55]. 
Therefore, despite the lower costs of the raw materials, 
the second generation biofuels are currently still more 
expensive than the bioethanol produced from corn or 
sugar cane. To make cellulosic ethanol price-competitive, 
and to pave the way for the use of lignocellulose as raw 
material also for other biotechnological processes, novel 
solutions will be required. The most promising ones aim 
at so-called third generation processes, enabled by con-
solidated bioprocessing (CBP). CBP requires a single 
organism capable of biomass hydrolysis and bio-product 
production [56]. In terms of scientific approaches, devel-
opment of such strains calls for merging of the fields of 
heterologous expression of cellulases and xylose fermen-
tation. In addition, strains for CBP will be needed that 
are capable of maintaining the correct levels of expres-
sion of heterologous proteins—often for both cellulose 
hydrolysis and specific product biosynthesis—and that 
are resistant to the high temperatures required for most 
efficient biomass hydrolysis, and to the inhibitory com-
pounds generated in this process. Hence, the assembly of 
strains for CBP is one of the most ambitious goals in the 
development of cell factories because it will require inte-
gration of knowledge from all the fields referred to above.
Enhancement of the product spectrum
The specialization of S. cerevisiae on fast fermentation of 
sugars is the basis for its use in the production of alco-
holic beverages and biofuel and in the baking industry. 
At the same time, aerobic ethanol fermentation (also 
called the Crabtree effect) is one of the main obstacles 
to obtaining high yields in processes aimed at produc-
ing bulk products other than ethanol. Indeed, sustain-
able and cost-effective production of many commercially 
important metabolites cannot be achieved in S. cerevisiae 
as long as most of the carbon source is converted to etha-
nol. Hence, a stable conversion of S. cerevisiae physiology 
to respiration in the presence of high sugar levels, allow-
ing efficient use of the substrate, is an important prereq-
uisite for its use in high yield production processes.
Most attempts to eliminate the Crabtree effect in S. cer-
evisiae focus mainly on a reduction of the normally high 
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glycolytic flux, because it is assumed that the degree of 
fermentative activity is a function of the rate of glucose 
catabolism [57, 58]. A promising approach towards this 
aim is deletion of the seven major hexose transport-
ers and their replacement with a chimeric transporter. 
These modifications result in reduced growth rates, but 
increased biomass yields and absence of ethanol produc-
tion at moderate glucose concentrations [58]. Whether 
this strain is sufficiently robust to be used in biotech-
nological processes remains to be shown but its supe-
rior properties in heterologous protein production have 
already been demonstrated [59]. On the other hand, aer-
obic fermentation and concurrent ethanol excretion can 
be seen as a trade-off for conditions that are less prone to 
contamination and require less aeration than processes 
with respiratory organisms. Furthermore, if the post-
diauxic ethanol consumption phase can be integrated 
into the production process, the product yield will be 
improved considerably. Importantly, the production of 
ethanol can be replaced with other pathways that balance 
the reducing equivalents originating from glycolysis. This 
has been successfully demonstrated with strains produc-
ing 2,3-butanediol [60] or lactate [61]. Hence, if a pro-
duction pathway includes a reductive NADH-dependent 
step, it might be possible to eliminate ethanol excretion.
Synthetic biology approaches have resulted in recom-
binant yeast strains for the production of metabolites 
that are not normally produced by this species (Figure 1, 
right). Prominent examples are amorphadiene [6] and 
vanillin [5]. Other studies aiming at the production of 
polyketides [62], isoprenoids [63, 64], steviol components 
[65] and opiates [66] suggest that there are no obvious 
limits to the type of biochemicals that can be produced 
in yeast. Many of the above mentioned products are 
derived from reductive pathways, mostly dependent on 
NADPH. Therefore, synthetic biology approaches aiming 
at high yields will have to address not only the synthesis 
pathway itself, but also the system-wide redox balance of 
the host. Computational modelling approaches will likely 
become an important tool in the future to predict opti-
mal engineering strategies for redox cofactor balance at 
high rates of product synthesis. The yeast community 
provides a continuously updated network reconstruc-
tion of yeast metabolism [67], which allows for metabolic 
modelling with simple flux balance analysis or with more 
complex methods like elementary flux mode analysis [68] 
and minimal metabolic behaviours [69]. Future efforts 
in this area will have to be focused on the integration of 
experimental data, like quantitative transcriptome, pro-
teome and metabolome data, in the models to improve 
predictions, since consideration of circumstantial data 
can both improve analysis and provide new leverage for 
in vivo and in silico design. This will require high quality 
data sets, which are still rather rare. Furthermore, the 
endogenous basic network reconstruction will have to be 
extended by a meta-genomic library of exogenous reac-
tions to enable optimal pathways for maximum produc-
tivity and cofactor-balanced metabolism to be predicted.
Orthogonality, although theoretically worthwhile, is 
difficult to achieve in biological systems. Nevertheless, 
it should be seen as one of the goals of synthetic biology 
in order to design modules for the supply of intermedi-
ate metabolites and cofactors with general applicability in 
metabolic engineering that are independent of the over-
all pathway which they serve. Examples would be circuits 
for regenerating redox cofactors or efficient modules 
for providing central building blocks such as 2-carbon 
(acetyl-CoA), four carbon (oxaloacetate), and six carbon 
(citrate) metabolites that can be of use in engineering 
many different pathways. Such readily available circuits 
would considerably facilitate metabolic engineering and 
enable faster expansion of the product spectrum of yeast.
Perspective: combining polygenic trait analysis 
with synthetic biology
Several genetic modules [70–75] show that mutations in 
genes encoding regulatory proteins enable expression of 
the studied trait. Using synthetic biology tools to engi-
neer trait-specific genetic modules can thus be seen as a 
step towards synthetic regulatory circuits with the abil-
ity to drastically increase the productivity of yeast strains. 
Since synthetic biology is not yet at the level of de novo 
organism design, this is, in our opinion, one of the most 
promising approaches towards a platform for yeast-based 
cell factories with an unprecedented lack of constraints, 
that are applicable to a wide range of biosynthetic path-
ways. Productive combination of genetic modules for 
tolerance to several stress factors will likewise remove 
some of the current bottlenecks in the development of 
new and more sophisticated cell factory-based processes. 
Although it remains to be seen how and if genetic inter-
actions will occur between introduced causal genes, and 
how they would affect the expression of a combination of 
traits, we expect that the resulting complex cell factories 
will play a crucial role in the biotechnology of tomorrow, 
providing flexibility and robustness for novel processes.
Improved substrate spectrum, enhanced product spec-
trum and increased stress tolerance and robustness are 
the main demands for the future cell factories that will be 
used in biorefineries (Figure 1). As described above, these 
traits are almost exclusively polygenic. Recently devel-
oped polygenic trait analysis methods, such as X-QTL 
and iQTL, enable identification of complete sets of causal 
alleles, i.e. genetic modules, for the desired traits. These 
traits are present in natural strains, and yeast biodiversity 
is therefore an attractive genetic pool for bioeconomy. 
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The development of synthetic biology toolboxes, on the 
other hand, enables genetic modules to be inserted into 
platform strains. We foresee an approach in which the 
latest developments in complex genetics are combined 
with expertise in synthetic biology, with the aim of com-
bining several genetic modules in single strains (Figure 1). 
This new approach will make it possible to combine mul-
tiple beneficial traits within a single organism, which is 
not possible in the current state-of-the-art. Specific com-
binations of traits could result in strains custom-made 
for requirements of specific processes. Such cell facto-
ries should have a big potential for future biorefineries 
where several sources of feedstock and several different 
products will be used/produced within a relatively short 
time intervals. It is the ability to transform different mol-
ecules into pre-defined end products which makes the 
multi-trait cell factories important within the value chain 
concept of bioeconomy. In addition, as multi-trait cell 
factories will contain genetic modules comprising heter-
ologous genes, the gap between biotechnological exploi-
tation of S. cerevisiae and so-called non-conventional 
species will be diminished, since we can envision that 
some cell factories could make use of S. cerevisiae only as 
a chassis, whereas the specific biotechnologically relevant 
traits will come from a number of different organisms.
Conclusions
New technologies for the analysis of whole genomes 
and for large scale DNA editing have the potential to 
revolutionize biotechnology. The engineering of produc-
tion strains will no longer be restricted by the length or 
complexity of a pathway and the use of computational 
and -omics tools will enable more accurate prediction 
and prevention of undesirable side effects in the design 
phase. Due to its current importance in biotechnology 
and its immense knowledge base, S. cerevisiae will most 
probably also play a role as a chassis for synthetic biology 
and for the next generation of production hosts in bio-
technology. The well-developed toolbox for the analysis 
of yeast, both on the single gene level and in -omics and 
systems biology techniques, is an important advantage of 
this organism. Combination of the recent developments 
in the fields of synthetic biology with polygenic trait 
analysis provides a means to engineer traits for increased 
stress tolerance and robustness, improved substrate spec-
trum, and enhanced product spectrum. However, syn-
thetic biology research in yeast lags behind that in other 
organisms, especially E. coli. Indeed, there are only few 
efforts to standardize engineering and to improve the 
collection of biological parts for yeast are only limited. 
To establish S. cerevisiae as a promising candidate as a 
chassis in synthetic biology and future biotechnology, 
research will have to catch up in several areas, such as the 
development of orthogonal parts for expression control 
and genome editing. These are not only aspects of aca-
demic relevance but also prerequisites for the rapid and 
predictable engineering of readily controllable synthetic 
hosts.
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